Showing 121-125 of 149 real-world data & outcomes research:
AAO-HNSF Partners With OM1 To Empower More Measured & Precise Care And Treatments For ENT

Collaboration enables otolaryngologists and researchers to leverage data for real-world evidence, outcomes, and personalized medicine programs BOSTON, May 13, 2020 — OM1, a real-world outcomes and technology company, today announced a strategic partnership with the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) connecting the Foundation’s Reg-entSM  clinical data registry to OM1’s real-world data[…]

Improving Depression Care

May 12, 2020 – Annals of Internal Medicine The development of standard diagnostic criteria for American Psychiatric Association, working with the New York Academy of Medicine, developed mental health classifications that were used in the American Medical Association’s Standard Classified Nomenclature of Dis-ease. In 1949, the World Health Organization published the sixth edition of their[…]

RWD for Research & Regulatory: Collecting, Processing and Leveraging High-Quality Data

Tuesday, March 31 – 1:00 – 2:00 pm ET Register The promise of real-world data is driving increased requirements and use. But, what does high-quality RWD actually look like? How should life sciences companies access and use it most effectively? What are the implications when applying RWD to clinical trials, registries, and other evidence and[…]

Tackling Rare Diseases With An Arsenal Of Real-World Data

Published February 28, 2020, HealthEconomics.com – written by Kathryn Starzyk, Senior Director, RWE, OM1 Technological innovations have fostered the age of big data in healthcare – and the huge populations amassed afford the ability to mine for key subpopulations — getting down to ever more precise groups of likely responders to therapy, high-risk patients and[…]